Evercore ISI raised the firm’s price target on Welltower to $92 from $90 and keeps an In Line rating on the shares. Heading into Q4 healthcare REIT earnings season, the firm raised its targets on four stocks in the group, reflecting slightly higher targeted forward AFFO multiples.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on WELL:
- Welltower price target raised to $95 from $90 at KeyBanc
- Welltower price target raised to $98 from $90 at Mizuho
- Welltower upgraded to Overweight from Neutral at JPMorgan
- Welltower downgraded to Sector Perform from Outperform at RBC Capital
- Welltower price target raised to $89 from $86 at Evercore ISI
